Literature DB >> 27815616

Estimated cumulative radiation dose received by diagnostic imaging during staging and treatment of operable Ewing sarcoma 2005-2012.

Boel Johnsen1, Kristine Eldevik Fasmer2, Kjetil Boye3, Karen Rosendahl4,5, Clement Trovik5,6, Martin Biermann7,5, Stein Magnus Aukland4,5.   

Abstract

BACKGROUND: Patients with Ewing sarcoma are subject to various diagnostic procedures that incur exposure to ionising radiation.
OBJECTIVE: To estimate the radiation doses received from all radiologic and nuclear imaging episodes during diagnosis and treatment, and to determine whether 18F-fluorodeoxyglucose positron emission tomography - computed tomography (18F-FDG PET-CT) is a major contributor of radiation.
MATERIALS AND METHODS: Twenty Ewing sarcoma patients diagnosed in Norway in 2005-2012 met the inclusion criteria (age <30 years, operable disease, uncomplicated chemotherapy and surgery, no metastasis or residual disease within a year of diagnosis). Radiation doses from all imaging during the first year were calculated for each patient.
RESULTS: The mean estimated cumulative radiation dose for all patients was 34 mSv (range: 6-70), radiography accounting for 3 mSv (range: 0.2-12), CT for 13 mSv (range: 2-28) and nuclear medicine for 18 mSv (range: 2-47). For the patients examined with PET-CT, the mean estimated cumulative effective dose was 38 mSv, of which PET-CT accounted for 14 mSv (37%).
CONCLUSION: There was large variation in number and type of examinations performed and also in estimated cumulative radiation dose. The mean radiation dose for patients examined with PET-CT was 23% higher than for patients not examined with PET-CT.

Entities:  

Keywords:  18F-fluorodeoxyglucose positron emission tomography – computed tomography (18F-FDG PET-CT); Adolescents; Children; Computed tomography; Ewing sarcoma; Oncological treatment protocol; Radiation dose; Radiography

Mesh:

Substances:

Year:  2016        PMID: 27815616     DOI: 10.1007/s00247-016-3720-x

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  17 in total

1.  Radiation doses for pediatric nuclear medicine studies: comparing the North American consensus guidelines and the pediatric dosage card of the European Association of Nuclear Medicine.

Authors:  Frederick D Grant; Michael J Gelfand; Laura A Drubach; S Ted Treves; Frederic H Fahey
Journal:  Pediatr Radiol       Date:  2014-11-01

2.  Estimated cumulative radiation dose from PET/CT in children with malignancies.

Authors:  Michael J Gelfand; Susan E Sharp; S Ted Treves; Frederic H Fahey; Marguerite T Parisi; Adam M Alessio
Journal:  Pediatr Radiol       Date:  2010-08-13

3.  Risk of cancer incidence before the age of 15 years after exposure to ionising radiation from computed tomography: results from a German cohort study.

Authors:  L Krille; S Dreger; R Schindel; T Albrecht; M Asmussen; J Barkhausen; J D Berthold; A Chavan; C Claussen; M Forsting; E A L Gianicolo; K Jablonka; A Jahnen; M Langer; M Laniado; J Lotz; H J Mentzel; A Queißer-Wahrendorf; O Rompel; I Schlick; K Schneider; M Schumacher; M Seidenbusch; C Spix; B Spors; G Staatz; T Vogl; J Wagner; G Weisser; H Zeeb; M Blettner
Journal:  Radiat Environ Biophys       Date:  2015-01-08       Impact factor: 1.925

4.  Estimated risks of radiation-induced fatal cancer from pediatric CT.

Authors:  D Brenner; C Elliston; E Hall; W Berdon
Journal:  AJR Am J Roentgenol       Date:  2001-02       Impact factor: 3.959

5.  Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors: 
Journal:  Ann Oncol       Date:  2014-09       Impact factor: 32.976

6.  Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines.

Authors:  Michael Lassmann; S Ted Treves
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-06       Impact factor: 9.236

7.  Radiation dose to patients from radiopharmaceuticals. A report of a Task Group of Committee 2 of the International Commission on Radiological Protection.

Authors: 
Journal:  Ann ICRP       Date:  1987

Review 8.  Minimizing and communicating radiation risk in pediatric nuclear medicine.

Authors:  Frederic H Fahey; S Ted Treves; S James Adelstein
Journal:  J Nucl Med Technol       Date:  2012-03

9.  Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007.

Authors: 
Journal:  Ann ICRP       Date:  2008

10.  Paediatric head CT scan and subsequent risk of malignancy and benign brain tumour: a nation-wide population-based cohort study.

Authors:  W-Y Huang; C-H Muo; C-Y Lin; Y-M Jen; M-H Yang; J-C Lin; F-C Sung; C-H Kao
Journal:  Br J Cancer       Date:  2014-02-25       Impact factor: 7.640

View more
  3 in total

1.  Cumulative radiation doses due to nuclear medicine examinations: a systematic review.

Authors:  Marco Brambilla; Agnieszka Kuchcińska; Roberta Matheoud; Alfredo Muni
Journal:  Br J Radiol       Date:  2021-08-11       Impact factor: 3.629

Review 2.  The cumulative radiation dose paradigm in pediatric imaging.

Authors:  Donald Frush
Journal:  Br J Radiol       Date:  2021-09-14       Impact factor: 3.629

Review 3.  Non-odontogenic tumors of the facial bones in children and adolescents: role of multiparametric imaging.

Authors:  Minerva Becker; Salvatore Stefanelli; Anne-Laure Rougemont; Pierre Alexandre Poletti; Laura Merlini
Journal:  Neuroradiology       Date:  2017-03-13       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.